Evidence map›Paper›PMID 27595404›Full record

ArticleNature methods2016

A proposal for validation of antibodies.

Mathias Uhlen, Anita Bandrowski, Steven Carr, Aled Edwards, Jan Ellenberg, Emma Lundberg, David L Rimm, Henry Rodriguez, Tara Hiltke, Michael Snyder and 1 more

Abstract read
In one paragraph

Article in Nature methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 359 papers.

0numbers the graph read from it
0cells of the map it votes in
359citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

359 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Single-Cell Protein Assays in Context: From 2D to 3D and In Situ Analysis.Annual review of analytical chemistry (Palo Alto, Calif.) · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Article

299 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Mathias UhlenScience for Life Laboratory, School of Biotechnology, KTH Royal Institute of Technology, Stockholm, Sweden.ORCID 0000-0002-4858-8056
Anita BandrowskiCenter for Research in Biological Systems, University of California at San Diego, San Diego, California, USA.
Steven CarrProteomics Platform, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
Aled EdwardsStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Jan EllenbergCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Emma LundbergScience for Life Laboratory, School of Biotechnology, KTH Royal Institute of Technology, Stockholm, Sweden.
David L RimmDepartment of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
Henry RodriguezOffice of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Tara HiltkeOffice of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Michael SnyderDepartment of Genetics, Stanford University School of Medicine, Stanford, California, USA.
Tadashi YamamotoBiofluid Biomarker Center, Niigata University, Niigata, Japan.

Funding

OPERATION, SUPPORT AND STRATEGIC ENHANCEMENT OF THE NEUROSCIENCE INFORMATION FRAMEWORKU24DA039832 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRETHE, JEFFREY S., MARTONE, MARYANN E · 2015 to 2016
$2.0M
NIDA NIH HHS U24 DA039832
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Validation Studies as TopicAntibodiesAntigensHumansReproducibility of ResultsAntibodiesAntigens

Identifiers

PMID27595404
PMCPMC10335836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.